Frontlight ResearchEarly access
Trial site
Institut Catala d'Oncologia (ICO)-Badalona
- 4running trials
- 1closed trial
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia2 trials
- Bladder cancer2 trials
- Head and neck cancer2 trials
- Acute lymphoblastic leukaemia1 trial
- Cervical cancer1 trial
- Chronic lymphocytic leukaemia1 trial
- Chronic myeloid leukaemia1 trial
- Colorectal cancer1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Kidney cancer1 trial
- Lung cancer1 trial
- and 6 more
- Phase
- Phase 1/22 trials
- Phase 32 trials
- Phase 11 trial
- Status
- Active, not recruiting2 trials
- Completed1 trial
- Not yet recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Eli Lilly and Company1 trial
- Grupo Español de Tratamiento de Tumores de Cabeza y Cuello1 trial
- Medicenna Therapeutics, Inc.1 trial
- Newave Pharmaceutical Inc1 trial
- PETHEMA Foundation1 trial
Running trials
Recruiting
Azacytidine, Venetoclax Plus Minus Quizartinib for First Line Older/Unfit AML Patients (VENP-A-QUI)
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Bladder cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 14 Nov 2026